Formulation development

Alcami's formulation development team proactively guides your development program every step of the way - from Compound to Clinic. Our team is adept at solving challenging formulations for new chemical entities (NCEs) and developing high-performance dose forms to meet today's consumer needs. We offer early-phase accelerated programs for NCEs and generic drug development for human and veterinary applications (ANDAs and ANADAs). Alcami's formulation development scientists provide full chemistry, manufacturing, and controls (CMC) services for drug candidates that encompass all biopharmaceutical classification system schemes (BCS Class I through Class IV) including the more challenging not freely soluble, unstable, or poorly bioavailable compounds. Our formulation and analytical experts can provide creative solutions to your toughest pharmaceutical challenges, including products with extremely low or high drug loads, poor flow, or homogeneity problems.